Drugs / Prismocal B22
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04215965 Comparator | May 2020 → Aug 2021 | — | Assistance Publique Hopitaux De Marseille | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prismocal B22 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04215965 ↗ |